Financing

Debt Repayments

Over 4 years (FY 2021 to FY 2025), Debt Repayments shows an upward trend with a 35.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryRisk
SignalHigher is better
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025

How to read this metric

Consistent repayment signals a strengthening balance sheet and a reduction in financial risk or leverage.

Detailed definition

The cash used to pay down the principal on outstanding loans, bonds, or commercial paper. This reduces the company's tot...

Peer comparison

Debt-heavy industries show high activity here; tech firms often use it to manage the maturity profile of their corporate bonds.

Metric ID: cf_debt_repayment

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$1.00B$1.00B$1.61B$0.00$0.00$1.69B$269.00M$1.00B$1.30B$0.00$1.25B$1.00B$0.00$0.00$0.00$3.75B$0.00$3.01B
QoQ Change+0.2%+60.4%-100.0%-84.1%+271.7%+30.0%-100.0%-20.0%-100.0%-100.0%
YoY Change-100.0%+68.4%-83.3%-100.0%+364.7%+0.0%-100.0%-100.0%+275.0%
Range$0.00$3.75B
Avg YoY Growth+25.0%
Median YoY Growth-83.3%

Frequently Asked Questions

What is Pfizer's debt repayments?
Pfizer (PFE) reported debt repayments of $3.01B in Q4 2025.
What is the long-term trend for Pfizer's debt repayments?
Over 4 years (2021 to 2025), Pfizer's debt repayments has grown at a 35.5% compound annual growth rate (CAGR), from $2.00B to $6.76B.
What does debt repayments mean?
The amount of money a company spent to pay back its borrowed debt.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.